Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Phase 1 / 2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies

Miscellaneous

A phase 1 / 2, open-label, study to determine the safety and preliminary efficacy of APR-246 in combination with pembrolizumab in subjects with solid tumor malignancies. The study will include a safety lead-in portion followed by a phase 2 expansion portion in specific disease groups.
Miscellaneous
I/II
Das, Satya
NCT04383938
VICCMD2037

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: